SLC5A2 and urinary tract infection: Previous observational study with SGLT2 inhibitor reported a higher prevalence of urinary tract infection particularly in female participants [30]; therefore, low urinary symptoms in the present study may be related to the higher percentage (65.4%) of the male participants.